KRMD
SellFallen FavouriteKORU Medical Systems, Inc. · Healthcare · United States · $148M · Avg Vol: $772K/d
Fallen Favourite: A good business that is expensive and falling. Wait for the price to catch up.
ABOUT KORU MEDICAL SYSTEMS, INC.
Read
KORU Medical Systems, Inc. designs, manufactures, and markets innovative medical devices and supplies for subcutaneous infusion, including the FREEDOM Infusion System. The company holds a strong position in the niche market of subcutaneous infusion, offering specialized and patient-friendly solutions that enhance convenience and adherence for chronic care patients. KORU Medical is a specialized healthcare device company, focusing on improving the quality of life for patients requiring regular subcutaneous infusions through its innovative delivery systems.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.9M | 28.5M | 33.6M | 41.1M | 13.8% | 45.1M | 48.0M | 56.3M | 17.0% |
| EPS | -0.19 | -0.30 | -0.13 | -0.06 | — | -0.04 | — | — | — |
| Shares | 45.4M | 45.7M | 46.0M | 46.4M | +2.0% | 45.9M | — | — | — |
| Debt | 4.9M | 4.4M | 4.0M | 3.5M | -10.8% | 3.3M | — | — | — |
| Equity | 31.3M | 20.4M | 16.8M | 17.0M | -18.4% | — | — | — | — |
| Op CF | -5.4M | -4.9M | -0.3M | 0.5M | — | 1.4M | — | — | — |
| Inv CF | -2.8M | -0.8M | -1.3M | -0.9M | — | — | — | — | — |
| Fin CF | 0.3M | -0.2M | -0.2M | -0.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of KRMD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| KRMD | KORU Medical Systems, Inc.(you) | $148M | 25 | Sell |
| OSUR | OraSure Technologies, Inc. | $248M | 33 | Sell |
| STXS | Stereotaxis, Inc. | $145M | 5 | Strong Sell |
| DXR | Daxor Corporation | $60M | 50 | Hold |
| KMTS | Kestra Medical Technologies, Ltd. | $1.5B | 26 | Sell |
| ANGO | AngioDynamics, Inc. | $655M | 52 | Hold |
| SMTI | Sanara MedTech Inc. | $318M | 68 | Buy |
| PLSE | Pulse Biosciences, Inc. | $3.4B | 22 | Sell |
| AZTA | Azenta, Inc. | $1.4B | 46 | Hold |
| WRBY | Warby Parker Inc. | $3.1B | 34 | Sell |
Peer medians: ROE -31.0% · P/E 25.1x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.